Lupin appoints Spiro Gavaris as President of U.S. Generics Business
Spiro will be responsible for the overall strategy, implementation and growth of Lupin’s U.S. Generics business
Spiro will be responsible for the overall strategy, implementation and growth of Lupin’s U.S. Generics business
The plant, to be built in the Incheon Free Economic Zone in Songdo, Incheon, will be a facility for the manufacture of products such as sterile bags, cell culture media and membrane filters
35 million mosquito nets supplied to countries in sub-Saharan Africa through partners
The funds raised through the issue will be utilised to meet the working capital requirements to fund the company's expansion plans, entering new geographies and for general corporate purposes
More women centric initiatives being the need of the hour for holistic development
GMP-compliant documentation of all manufacturing steps for cell and gene therapies
Natco Chlorantraniliprole (CTPR) Process does not infringe FMC's Indian Patent 298645.
The two-day event focused on the multi-faceted relationship of clinical research stakeholders and looked at bridging the academic and clinical research gap.
It offers quick relief in various types of Coughs, Colds and Sore Throat,
Expanded capacity in Nansha, China will support mid-scale manufacturing to ensure a smooth transition between early-phase and large-scale commercial production
Subscribe To Our Newsletter & Stay Updated